Related Experiment Video

Updated: Sep 20, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

[Stat3 signal transduction pathway orchestrates G1 to S cell cycle transition in colon cancer cells]

Xiangtao Ma1, Shan Wang, Ruyu Du

  • 1Department II of Surgery, Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing 100044, China. tonyma72@yahoo.com.cn

Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|August 19, 2003
PubMed
Abstract

Insights

Signal transducer and activator of transcription 3 (Stat3) is crucial for colon cancer cell cycle progression. Inhibiting Stat3 halts cell proliferation by regulating G1 to S phase transition.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell cycle regulation

Context:

  • Constitutively activated Signal transducer and activator of transcription 3 (Stat3) is observed in human colon cancer cell lines SW480 and HCT116.
  • Stat3 signaling is implicated in various cancers, but its precise role in colon cancer cell cycle progression requires further elucidation.

Purpose:

  • To investigate the role of Stat3 in the G1 to S phase transition of colon cancer cells.
  • To determine the effect of Stat3 inhibition on colon cancer cell proliferation and cell cycle regulators.

Summary:

  • Human colon cancer cell lines SW480 and HCT116 were treated with Stat3 antisense oligonucleotide.
  • Cell proliferation was assessed using MTT assay, and cell cycle distribution was analyzed by flow cytometry.
  • Western blot analysis measured the expression of Stat3, phosphorylated Stat3 (p-Stat3), Cyclins (D1, E), Cyclin-dependent kinases (CDKs: 2, 4, 6), and CDK inhibitors (p21, p27).

Impact:

  • Targeting Stat3 with antisense oligonucleotides inhibited colon cancer cell growth.
  • Stat3 inhibition led to downregulation of Stat3, p-Stat3, Cyclins, and CDKs, and upregulation of p21 and p27.
  • These findings indicate Stat3's critical role in orchestrating the G1 to S phase transition by modulating the balance between CDK/Cyclin complexes and CDK inhibitors in colon cancer.

More Related Videos

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.